Dépêches

Gevo Receives Key Patent from USPTO for Efficient Production of Isobutanol

Dépèche transmise le 6 décembre 2011 par Business Wire

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Gevo, Inc. (NASDAQ: GEVO), a renewable chemicals and advanced biofuels company, today received a patent from the United States Patent and Trademark Office (“USPTO”) on another aspect of its yeast technology that enables the low-cost, high-yield production of biobased isobutanol.

“We continue to expect the breadth and strength of our patent estate to grow considerably over the coming months as our patent applications convert into issued patents.”

Gevo was awarded U.S. Patent No. 8,017,358, covering additional “Methods of Increasing Dihydroxy Acid Dehydratase (DHAD) Activity to Improve Production of Fuels, Chemicals, and Amino Acids.”

“This invention further details and protects the innovations contained in the Gevo yeast organism to turn an industrial yeast strain into a highly efficient cell factory to produce isobutanol,” said Brett Lund, EVP & General Counsel of Gevo. “We continue to expect the breadth and strength of our patent estate to grow considerably over the coming months as our patent applications convert into issued patents.”

About Gevo

Gevo is converting existing ethanol plants into biorefineries to make renewable building block products for the chemical and fuel industries. The Company plans to convert renewable raw materials into isobutanol and renewable hydrocarbons that can be directly integrated on a “drop in” basis into existing chemical and fuel products to deliver environmental and economic benefits. Gevo is committed to a sustainable biobased economy that meets society’s needs for plentiful food and clean air and water. For more information, visit www.gevo.com.

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to a variety of matters, including but not limited to the strength of the Company’s intellectual property position, the conversion of the Company’s pending patent applications into granted patents and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise.

Although the company believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2010, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Gevo.